Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Our Ask-the-Analyst service is your direct hotline to the team of experts who cover all aspects of the Pharmaceutical market including R&D, clinical trials, market access, financing and licensing. As a Medtrack subscriber, you will receive 24/7 access to our expert analysts who can answer your business development and licensing questions and will provide a
detailed response to your query, spending up to 3 hours per question they receive and will respond within 48 hours, subject to your terms and conditions.
The following examples are actual questions received from Medtrack subscribers, along with their sample responses from the Medtrack analyst team.
Scrip: industry news and insights
As the death toll rises in China and new cases emerge in other countries, researchers are aiming to slash development times to generate a vaccine against the 2019-nCoV coronavirus.
Topics Coronavirus Research Vaccines
Medtech Insight: global medical technology news & analysis
By Sue Darcey
Bioresearchers at the Centers for Disease Control and Prevention are hoping that diagnostic platforms previously used to develop tests for outbreaks of other epidemic respiratory diseases, including SARS and MERS, can be built on to develop new diagnostics to detect more cases in the current coronavirus outbreak, US infectious disease authorities say. This comes as more patients are monitored around the US for the disease, and a Chicago woman returning from China tests positive.
Topics Drug approval Clinical Trials Coronavirus Policy and regulation
Medtech Insight: global medical technology news & analysis
By Sue Darcey
The US Food and Drug Administration (FDA) stands poised to proceed with hastened approvals for 2019-coronavirus (nCoV) diagnostics, treatments and vaccines, if a public health emergency is declared, after an infected US traveler who caught the disease in Wuhan, China returned from the province to Washington State. Spread of the disease has reached a crisis level in China, and the World Health Organization met on 22 and 23 January to consider what actions to take to contain the virus, while issuing an interim laboratory test guidance for use in diagnosing the disease.
Topics Drug approval Clinical Trials Coronavirus Policy and regulation
Request a Demo
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
How can we help you?
Our team is always happy to hear from you. Please call us at:
Pharma Report Store
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now:
Biomedtracker provides real-time analysis of major market-moving events in the pharma and biotech industries. With catalyst tracking and expert insights, you stay on top of breaking events, what’s in the drugs pipeline, upcoming milestones, clinical trial results and their impact on the markets you care about
Understand what’s happening in the market right now and what it means for the future of your business with news and insight from our team of journalists and analysts. Scrip is essential for anyone making commercial decisions in the pharmaceutical industry.
Analyze and track key healthcare deals with the premium source used by top pharmaceutical firms and leaders in medical devices, diagnostics, finance, and consulting. Turn to Strategic Transactions for pharmaceutical transactions intelligence that’s the best in the industry.
Looking for more products Product Finder
